CS
ASMB icon

Credit Suisse’s Assembly Biosciences ASMB Stock Holding History

Credit Suisse’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,094
Closed -$115K – 4442
2021
Q1 		$115K Sell
2,094
-824
-28% -$54.6K ﹤0.01% 4186
2020
Q4 		$212K Sell
2,918
-860
-23% -$101K ﹤0.01% 4077
2020
Q3 		$746K Sell
3,778
-1,206
-24% -$304K ﹤0.01% 3142
2020
Q2 		$1.4M Buy
4,984
+2,721
+120% +$635K ﹤0.01% 2669
2020
Q1 		$402K Buy
2,263
+959
+74% +$206K ﹤0.01% 3240
2019
Q4 		$321K Buy
1,304
+126
+11% +$23.2K ﹤0.01% 3792
2019
Q3 		$139K Sell
1,178
-349
-23% -$52.8K ﹤0.01% 3931
2019
Q2 		$246K Buy
1,527
+318
+26% +$60.4K ﹤0.01% 3768
2019
Q1 		$286K Sell
1,209
-101
-8% -$25.6K ﹤0.01% 3619
2018
Q4 		$356K Buy
1,310
+183
+16% +$52.9K ﹤0.01% 3439
2018
Q3 		$502K Sell
1,127
-434
-28% -$203K ﹤0.01% 3296
2018
Q2 		$734K Sell
1,561
-283
-15% -$150K ﹤0.01% 3227
2018
Q1 		$1.09M Buy
1,844
+687
+59% +$426K ﹤0.01% 2896
2017
Q4 		$628K Buy
1,157
+257
+29% +$116K ﹤0.01% 3309
2017
Q3 		$377K Buy
+900
New +$276K ﹤0.01% 3633
2016
Q4 		– Sell
-1,255
Closed -$109K – 4086
2016
Q3 		$109K Sell
1,255
-2,844
-69% -$220K ﹤0.01% 3916
2016
Q2 		$273K Buy
4,099
+3,228
+371% +$212K ﹤0.01% 3737
2016
Q1 		$52K Buy
871
+32
+4% +$2.14K ﹤0.01% 3885
2015
Q4 		$76K Buy
+839
New +$91.4K ﹤0.01% 4099
2015
Q3 		– Sell
-1,026
Closed -$237K – 4259
2015
Q2 		$237K Buy
+1,026
New +$198K ﹤0.01% 4140

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Credit Suisse's ASMB Position: Q2 2021 in Review

Credit Suisse sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 2,094 shares — an estimated $115K sold.

Credit Suisse first reported a position in ASMB in Q2 2015 and held it in 20 quarters. The position peaked at $1.4M in Q2 2020. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • Credit Suisse reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • Credit Suisse sold 2,094 Assembly Biosciences shares in Q2 2021, an estimated $115K.
  • Credit Suisse first reported a position in Assembly Biosciences in Q2 2015 and held it in 20 quarters.
  • Credit Suisse's Assembly Biosciences position peaked at $1.4M in Q2 2020.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.